UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epidemiological Overview of Hodgkin Lymphoma across the Mediterranean Basin

Mediterranean journal of hematology and infectious diseases, 2014-01, Vol.6 (1), p.e2014048-e2014048

2014

Volltextzugriff (PDF)

A 96-well assay for uronic acid carbazole reaction

Carbohydrate polymers, 2003-10, Vol.54 (1), p.59-61

2003

Volltextzugriff (PDF)

Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas

American journal of hematology, 2020-02, Vol.95 (2), p.151-155

2020

Volltextzugriff (PDF)

A phase II study of bendamustine in combination with rituximab as initial treatment for patients with indolent non-follicular non-Hodgkin lymphoma

Leukemia & lymphoma, 2016-04, Vol.57 (4), p.880-887

2016

Volltextzugriff (PDF)

Dismal outcome of t-cell lymphoma patients failing first-line treatment: results of a population-based study from the Modena Cancer Registry

Hematological oncology, 2015-09, Vol.33 (3), p.147-151

2015

Volltextzugriff (PDF)

Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: a Fondazione Italiana Linfomi phase II study

Leukemia & lymphoma, 2015-12, Vol.56 (12), p.3281-3287

2015

Volltextzugriff (PDF)

Addition of Rituximab to Front-Line-Treatment Highly Improved the Outcome of Elderly Patients with Follicular Lymphoma: a Population Based-Study From the Modena Cancer Registry

Blood, 2012-11, Vol.120 (21), p.5077-5077

2012

Volltextzugriff (PDF)

Isolation and characterization of a heparin with high anticoagulant activity from the clam Tapes phylippinarum: evidence for the presence of a high content of antithrombin III binding site

Glycobiology (Oxford), 2004-12, Vol.14 (12), p.1275-1284

2004

Volltextzugriff (PDF)

Purification and characterization of heparin from the Italian clam Callista chione

Biomacromolecules, 2005-05, Vol.6 (3), p.1672-1678

2005

Volltextzugriff (PDF)

The Outcome of T-Cell Lymphoma Patients Failing First-Line Treatment: Results of a Population Based-Study From the Modena Cancer Registry

Blood, 2012-11, Vol.120 (21), p.1611-1611

2012

Volltextzugriff (PDF)

NF10 Project: An International, Prospective, Observational Study Of Patients With Indolent Non-Follicular Lymphoma. Analysis Of First 215 Patients

Blood, 2013-11, Vol.122 (21), p.1782-1782

2013

Volltextzugriff (PDF)

Results of a Phase II Study of Lenalidomide in Combination with Rituximab for the Treatment of Indolent Non Follicular Non Hodgkin Lymphoma (NHL)

Blood, 2012-11, Vol.120 (21), p.1645-1645

2012

Volltextzugriff (PDF)

Purification and Characterization of Heparin from the Italian Clam Callista c hione

Biomacromolecules, 2005-05, Vol.6 (3), p.1672-1678

2005

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(37)
Berichte
(1)

Sprache

Englisch
(38)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Life Sciences & Biomedicine
(18)
Hematology
(14)
Humans
(12)
Aged
(11)
Female
(10)
Male
(10)
Adult
(9)
Middle Aged
(9)
Oncology
(7)
Aged, 80 And Over
(6)
Treatment Outcome
(6)
Italy
(5)
Prognosis
(5)
Rituximab
(5)
Adolescent
(4)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)
Retrospective Studies
(4)
Young Adult
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi

Epidemiological Overview of Hodgkin Lymphoma across the Mediterranean Basin

Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study

Lenalidomide plus rituximab for the initial treatment of frail older patients with DLBCL: the FIL_ReRi phase 2 study

A 96-well assay for uronic acid carbazole reaction

Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas

Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study

Early Progression As a Predictor of Survival in Marginal Zone Lymphomas: An Analysis from the Prospective International NF10 Study By Fondazione Italiana Linfomi

A phase II study of bendamustine in combination with rituximab as initial treatment for patients with indolent non-follicular non-Hodgkin lymphoma

IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma

Bendamustine in Combination with Rituximab As First-Line Treatment of Splenic Marginal Zone Lymphoma (BRISMA). Results of the IELSG-36 Phase II Study

Dismal outcome of t-cell lymphoma patients failing first-line treatment: results of a population-based study from the Modena Cancer Registry

Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: a Fondazione Italiana Linfomi phase II study

Real Life Data on Clinical Aspects and Treatment of Marginal Zone Lymphoma: An Analysis from the NF10 Project, an International, Prospective, Observational Study of the Fondazione Italiana Linfomi

Addition of Rituximab to Front-Line-Treatment Highly Improved the Outcome of Elderly Patients with Follicular Lymphoma: a Population Based-Study From the Modena Cancer Registry

Prognostic role of gender in diffuse large B-cell lymphoma treated with rituximab containing regimens: a Fondazione Italiana Linfomi/Grupo de Estudos em Moléstias Onco-Hematológicas retrospective study

Isolation and characterization of a heparin with high anticoagulant activity from the clam Tapes phylippinarum: evidence for the presence of a high content of antithrombin III binding site

Purification and characterization of heparin from the Italian clam Callista chione

Pattern of Care in Indolent Non Follicular Lymphoma: A Report from NF10 Project, an International, Prospective, Observational Study Coordinated By the Fondazione Italiana Linfomi

The Outcome of T-Cell Lymphoma Patients Failing First-Line Treatment: Results of a Population Based-Study From the Modena Cancer Registry

Bendamustine and Rituximab Combination In Untreated Indolent Non Follicular B-Cell Non-Hodgkin's Lymphomas. A Phase II Study From The Fondazione Italiana Linfomi (INFL09)

NF10 Project: An International, Prospective, Observational Study Of Patients With Indolent Non-Follicular Lymphoma. Analysis Of First 215 Patients

Results of a Phase II Study of Lenalidomide in Combination with Rituximab for the Treatment of Indolent Non Follicular Non Hodgkin Lymphoma (NHL)

Final Results Of a Phase II Study Of Lenalidomide In Combination With Rituximab For The Treatment Of Indolent Non Follicular Non Hodgkin Lymphoma

Purification and Characterization of Heparin from the Italian Clam Callista c hione

Suchergebnisse filtern